###begin article-title 0
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx </italic>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Ascl1 is a required downstream effector of Gsx gene function in the embryonic mouse telencephalon
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsh2</italic>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 211 215 211 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsh1</italic>
The homeobox gene Gsx2 (formerly Gsh2) is known to regulate patterning in the lateral ganglionic eminence (LGE) of the embryonic telencephalon. In its absence, the closely related gene Gsx1 (previously known as Gsh1) can partially compensate in the patterning and differentiation of ventral telencephalic structures, such as the striatum. However, the cellular and molecular mechanisms underlying this compensation remain unclear.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1</italic>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 397 408 397 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 495 505 495 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 595 606 595 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 830 836 830 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 887 898 887 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
We show here that in the Gsx2 mutants Gsx1 is expressed in only a subset of the ventral telencephalic progenitors that normally express Gsx2. Based on the similarities in the expression of Gsx1 and Ascl1 (Mash1) within the Gsx2 mutant LGE, we examined whether Ascl1 plays an integral part in the Gsx1-based recovery. Ascl1 mutants show only modest alterations in striatal development; however, in Gsx2;Ascl1 double mutants, striatal development is severely affected, similar to that seen in the Gsx1;Gsx2 double mutants. This is despite the fact that Gsx1 is expressed, and even expands, in the Gsx2;Ascl1 mutant LGE, comparable to that seen in the Gsx2 mutant. Finally, Notch signaling has recently been suggested to be required for normal striatal development. In spite of the fact that Notch signaling is severely disrupted in Ascl1 mutants, it actually appears to be improved in the Gsx2;Ascl1 double mutants.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
These results, therefore, reveal a non-proneural requirement of Ascl1 that together with Gsx1 compensates for the loss of Gsx2 in a subset of LGE progenitors.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsh2</italic>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 296 302 296 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mash1</italic>
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlx </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 487 488 487 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 645 646 645 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 647 648 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 649 650 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
The homeobox gene Gsx2 (formerly known as Gsh2) has been shown to be required for correct dorsal-ventral patterning in the embryonic mouse telencephalon [1-3]. Gsx2 accomplishes this by repressing dorsal telencephalic genes such as Pax6 and promoting the expression of ventral regulators such as Ascl1 (Mash1) and Dlx genes within ventricular zone (VZ) and subventricular zone (SVZ) progenitors of the lateral ganglionic eminence (LGE). Although Gsx2 mutants do not survive after birth [4], analyses at late embryonic stages have demonstrated severe reductions in markers of striatal projection neurons as well as olfactory bulb interneurons [1-3,5,6], both of which are derived from the LGE [7-10].
###end p 9
###begin p 10
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsh1</italic>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 150 151 150 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 370 375 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 592 597 592 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlx </italic>
###xml 860 861 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 862 863 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 871 877 871 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 881 885 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlx </italic>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1040 1046 1040 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1050 1054 1050 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlx </italic>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 1217 1222 1217 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1283 1289 1283 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1292 1296 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dlx </italic>
The closely related Gsx1 (Gsh1) is also expressed in the embryonic ventral telencephalon [11], although no telencephalic phenotype has been reported [5,6]. Despite this, removal of Gsx1 on the Gsx2 mutant background eliminates nearly all striatal projection neurons and olfactory bulb interneurons, suggesting that Gsx1 can, at least in part, compensate for the loss of Gsx2 in the development of these ventral telencephalic structures. This compensation, however, is complex because Gsx1 is normally only present in the medial ganglionic eminence and the ventral-most portion of the LGE. In Gsx2 mutants, Gsx1 expression spreads dorsally to encompass the mutant LGE at mid-neurogenesis time points (for example, embryonic day (E)14), which is coincident with the re-establishment of ventral identity (for example, Ascl1 and Dlx expression) in the mutant LGE [5,6]. Both Ascl1 and Dlx genes are known to be required for normal development of the striatum and olfactory bulb interneurons [12-16]. Moreover, a recent study [17] suggests that Ascl1 and Dlx genes control distinct and parallel pathways that act in the specification of olfactory bulb interneurons. The mechanism by which Gsx1 compensates for the loss of Gsx2 has not been fully elucidated. Moreover, the requirement for Ascl1 or Dlx genes in this process is unclear.
###end p 10
###begin p 11
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1</italic>
###xml 130 135 130 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 191 196 191 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 212 223 212 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 279 285 279 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 378 388 378 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1:Gsx2 </italic>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 442 448 442 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1</italic>
###xml 546 551 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
In this study we have examined the molecular mechanisms underlying Gsx1-mediated recovery of ventral telencephalic development in Gsx2 mutants. To do this, we have generated and analyzed Gsx2EGFP mice as well as Gsx2;Ascl1 double mutants at multiple embryonic stages. Removal of Ascl1 from the Gsx2 mutant background results in a telencephalic phenotype nearly identical to the Gsx1:Gsx2 double mutant [5,6]. These results thus indicate that Ascl1 is an essential component of the Gsx1-mediated recovery in a subset of LGE progenitors within the Gsx2 mutant telencephalon.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
Gsx1 expression in the Gsx2 mutant telencephalon
###end title 13
###begin p 14
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 186 191 186 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 361 366 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A&#8211;C</xref>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 669 673 669 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 669 679 669 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 782 787 782 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 855 859 855 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F&#8211;H</xref>
###xml 960 965 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 980 981 980 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 982 983 982 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1079 1081 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
Previous studies have shown that Gsx1 expands in the LGE of the Gsx2 mutant [3,5,6]. Normally, the cells expressing Gsx1 are confined to the ventral-most portion of the LGE; however, in Gsx2 mutants the expression of this gene expands throughout the entire dorsal-ventral extent of the LGE between E11 and E14. We have generated mice in which the first exon of Gsx2 is interrupted by an IRES-enhanced green fluorescent protein (EGFP) cassette so that EGFP is expressed in place of Gsx2. These mice appear to faithfully reproduce Gsx2 expression and provide a short-term fate map of Gsx2 derived cells that no longer express the protein (Figure 1A-C). Moreover, the Gsx2EGFP/EGFP embryos lack Gsx2 protein expression, while still delineating the portion of the LGE that the targeted Gsx2 gene is being transcribed in by virtue of the EGFP staining (Figure 1F-H). These mutants exhibit identical patterning defects to those reported for the previously available Gsx2 mutant allele [1-4] (data not shown). Using these mice together with an antibody that detects both Gsx1 and Gsx2 [18], we were able to examine the Gsx1 recovery on a cellular level, within the context of the Gsx2 expression domain.
###end p 14
###begin p 15
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Knock-in of enhanced green fluorescent protein (EGFP) into the <italic>Gsx2 </italic>locus</bold>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 105 112 105 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 179 183 179 183 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 564 570 564 570 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F-H) </bold>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 623 627 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 628 632 628 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 623 632 623 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP</italic></sup>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 781 786 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 776 786 776 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 818 822 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 818 825 818 825 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 838 842 838 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I) </bold>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 897 901 897 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 892 901 892 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP</italic></sup>
###xml 962 966 962 966 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(J) </bold>
Knock-in of enhanced green fluorescent protein (EGFP) into the Gsx2 locus. (A, B) EGFP expression in Gsx2EGFP/+ embryos (A) recapitulates endogenous Gsx2 expression at E12.5 (B). (C) Note that EGFP expression persists longer than Gsx2 protein expression in the lateral ganglionic eminence (LGE; merged image). - (D) The Gsx1/2 antibody detects expression of Gsx1 and Gsx2 in the ventral telencephalon. (E) Note that the EGFP expression is absent in the septal expression domain of the Gsx1/2 antibody (asterisks in D, E, I, J) indicating Gsx1-specific expression. (F-H) Homozygous knock-in of EGFP into the Gsx2 locus (Gsx2EGFP/EGFP) (F) results in a loss of function of Gsx2 with no detectable protein expression (G). Note that the EGFP expression is more intense in the Gsx2EGFP/EGFP embryos (H) compared to the Gsx2EGFP/+ embryos (A). (I) The initial expansion of Gsx1 into the LGE of Gsx2EGFP/EGFPembryos is detectable at E12.5 with an anti-Gsx1/2 antibody. (J) Gsx1 expression is not observed in all Gsx2 mutant cells of the LGE (merged image) but found largely at the VZ/SVZ boundary (arrows in I, J).
###end p 15
###begin p 16
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 81 88 81 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A&#8211;E</xref>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 160 170 160 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 186 191 186 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1I, J</xref>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 553 558 553 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1I, J</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 804 809 804 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 824 829 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 877 878 877 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 881 882 881 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 936 940 936 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 940 944 940 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 945 950 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 940 950 940 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 1272 1276 1272 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 1276 1283 1276 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 1298 1300 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1387 1391 1387 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A&#8211;C</xref>
###xml 1543 1544 1543 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1545 1546 1545 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
While the Gsx1/2 antibody staining looks very similar to that of Gsx2 in the Gsx2EGFP/+ embryos (Figure 1A-E), it reveals a rather different pattern in the Gsx2EGFP/EGFP embryos (Figure 1I, J). At E12.5, the cells expressing Gsx1 in the mutant LGE are few in number and largely confined to its ventral half. This finding is in agreement with previous Gsx1 gene expression studies [3,5]; however, the cellular resolution afforded by the immunohistochemical approach revealed that the Gsx1 cells appear mostly at the border between the VZ and SVZ (Figure 1I, J). This is different from Gsx2 expression in the wild-type LGE where cells throughout the apical-basal extent of the VZ express this protein, albeit at different levels of expression (Figure 1B). Previous studies have shown that the expansion of Gsx1 throughout the Gsx2 mutant LGE is complete between E14.5 and E16.5 [3,5,6]. This is clearly revealed by Gsx1/2 staining in the Gsx2EGFP/EGFP mutants at E16.5 (Figure 2G). At this stage, only around half the LGE cells that would normally express Gsx2 contain Gsx1 staining. Again, the majority of the Gsx1 expressing cells appear to line up at the VZ/SVZ boundary (Figure 2H). This is similar to Gsx1/2 staining in the remnant of the medial ganglionic eminence in Gsx2EGFP/+ brains (Figure 2B), and since this staining does not coincide with the EGFP from the Gsx2 locus (Figure 2A-C), it is likely to reflect Gsx1 expression in the wild-type medial ganglionic eminence. Thus, although Gsx1 can at least partially compensate for Gsx2 [5,6], it does not do so in all cells of the LGE that would normally express Gsx2 but only in a subpopulation positioned at the VZ/SVZ boundary.
###end p 16
###begin p 17
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 29 39 29 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 0 167 0 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expansion of Gsx1 in the <italic>Gsx2</italic><sup><italic>EGFP</italic>/<italic>EGFP </italic></sup>lateral ganglionic eminence (LGE) occurs in only a subset of cells at the ventricular zone (VZ)/subventricular zone (SVZ) border</bold>
###xml 169 175 169 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-C) </bold>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 196 200 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 196 202 196 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+</sup>
###xml 663 667 663 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) </bold>
###xml 692 696 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 696 700 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 701 706 701 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 696 706 696 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 746 753 746 753 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F, H) </bold>
###xml 782 786 782 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 786 796 786 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 988 995 988 995 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D, E) </bold>
###xml 1012 1016 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 1016 1020 1016 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 1016 1022 1016 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+</sup>
###xml 1154 1158 1154 1158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I) </bold>
###xml 1201 1205 1201 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 1205 1209 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 1210 1215 1210 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 1205 1215 1205 1215 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
Expansion of Gsx1 in the Gsx2EGFP/EGFP lateral ganglionic eminence (LGE) occurs in only a subset of cells at the ventricular zone (VZ)/subventricular zone (SVZ) border. (A-C) Control embryos (Gsx2EGFP/+) express Gsx2 and enhanced green fluorescent protein (EGFP) throughout the VZ of the LGE at E16.5. In addition, the Gsx1/2 antibody labels scattered cells in the SVZ (B) where EGFP expression is observed in the majority of the SVZ (A, C). Asterisks in (A, C) mark Gsx1/2 staining in the remnant of the medial ganglionic eminence. Because EGFP expression from the Gsx2 locus is not found in this region, it is likely that the staining reflects Gsx1 expression. (G) The expansion of Gsx1 in Gsx2EGFP/EGFP embryos is throughout the LGE at E16.5. (F, H) Note that Gsx1 expression in Gsx2EGFP/EGFP embryos is observed only at the VZ/SVZ border in the LGE (arrows in merged image in (H)) whereas EGFP expression (labeling Gsx2 mutant cells) is observed throughout the VZ and the SVZ (F, H). (D, E) Control embryos (Gsx2EGFP/+) express Ascl1 at highest levels near the VZ/SVZ border (D) and only in scattered cells of the VZ (merged image with EGFP in (E)). (I) By E16.5, Ascl1 is recovered in the LGE of Gsx2EGFP/EGFP embryos predominately at the VZ/SVZ border (arrows in (J)), which is similar to the expansion of Gsx1 expression in these mutants (G).
###end p 17
###begin title 18
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
Relationship between Gsx1 and Ascl1 in the Gsx2 mutant LGE
###end title 18
###begin p 19
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 326 333 326 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 401 406 401 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D, E</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G&#8211;J</xref>
###xml 645 655 645 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1053 1058 1053 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1077 1082 1077 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H, J</xref>
###xml 1176 1181 1176 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
Ascl1 (Mash1) is known to be required for the normal development of the ventral telencephalon [14-16]. Furthermore, Ascl1 is dependent on Gsx2 for its normal expression in LGE progenitor cells [1-3], at least at early stages, before Gsx1 expression expands into the mutant LGE. Ascl1 is expressed by many cells within the Gsx2EGFP/+ VZ, although they are mainly located at the VZ/SVZ boundary (Figure 2D, E). Interestingly, the pattern of Ascl1 expression in the Gsx2 mutants is very similar to that of Gsx1 (as revealed by Gsx1/2 staining; Figure 2G-J), with scattered cells in the VZ and the majority accumulated along the VZ/SVZ boundary. In Gsx1;Gsx2 double mutants, Ascl1 is not expressed in the LGE at early stages (for example, E12.5) but at later stages (for example, E15.5-16.5) it is found at low levels within the presumptive LGE region [5,6]. This suggests that although Gsx proteins are not absolutely required for Ascl1 expression in the LGE, they are positive regulators of its expression. The overlap in Gsx1 and Ascl1 expression in the Gsx2 mutant LGE (Figure 2H, J) therefore suggests that Ascl1 may act in concert with Gsx1 for the compensation observed in Gsx2 mutants.
###end p 19
###begin title 20
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
Expression of Gsx2 in the Ascl1 mutant
###end title 20
###begin p 21
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1</italic>
###xml 177 181 177 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 315 320 315 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, D</xref>
###xml 481 487 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 684 689 684 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E, F</xref>
###xml 816 821 816 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 862 868 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 970 974 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx </italic>
Although Ascl1 expression in LGE progenitors has been shown to require Gsx2 [1-3], the role (if any) of Ascl1 in regulating Gsx2 expression has not been reported. In E12.5 Ascl1-/- mutants, we found that Gsx2 (and Gsx1/2) staining in the LGE was not significantly different from that observed in wild types (Figure 3A, D and data not shown). Conversely, at E18.5 we observed a large increase in the numbers of cells expressing Gsx2 along the dorsal-ventral aspect of the VZ in the Ascl1 mutants and in certain cases clusters of Gsx2 expressing cells were found in the forming striatum (Figure 3E). The expression of Gsx2 coincided with Ki67 staining in many of these clusters (Figure 3E, F) on closely adjacent sections, suggesting that despite their ectopic location, these Gsx2 cells may remain in the cell cycle. Gsx1 expression was not changed in the LGE of Ascl1 mutants [19] (data not shown). These findings could indicate that, in addition to being downstream of Gsx genes, Ascl1 may also serve a negative feedback function to repress Gsx2 in LGE progenitors, particularly at late embryonic stages.
###end p 21
###begin p 22
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increase in progenitor cell markers in the lateral ganglionic eminence (LGE) of Ascl1 mutants</bold>
###xml 95 102 95 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A, D) </bold>
###xml 315 322 315 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, E) </bold>
###xml 587 594 587 594 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C, F) </bold>
Increase in progenitor cell markers in the lateral ganglionic eminence (LGE) of Ascl1 mutants. (A, D) At E12.5, Ascl1 mutants express Gsx2 in a relatively normal pattern in the LGE compared to wild type. Note the odd morphology in the developing medial ganglionic eminence (MGE) of Ascl1 mutants (asterisk in (D)). (B, E) By E18.5, Gsx2 protein expression is increased in the entire LGE region of Ascl1 mutants (E) compared to controls (B). These ectopic Gsx2 positive cells are observed in the SVZ and striatum, many appearing as clumps of cells stuck in the parenchyma (arrow in (E)). (C, F) Dividing cells labeled by Ki67 expression are also increased in the Ascl1 mutant LGE area (F) compared to control (C). Similar to Gsx2, many ectopic Ki67 positive cells appear as clumps (arrow in (F)).
###end p 22
###begin title 23
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
Gsx2;Ascl1 double mutants exhibit severe striatal defects
###end title 23
###begin p 24
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 123 134 123 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 440 445 440 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A, B</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 707 718 707 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
To examine the possibility that Ascl1 is required for the Gsx1-mediated recovery observed in the Gsx2 mutant, we generated Gsx2;Ascl1 double homozygous mutants and analyzed the striatum at E18.5. The expression of FoxP1 can be used to mark striatal neurons and, thus, the forming striatum at this stage [20,21]. Staining for this marker shows that the size of the striatum in Gsx2 mutants is severely reduced compared to wild types (Figure 4A, B), which is consistent with previous studies [1-3,5,6]. Unlike the Gsx2 mutants, however, Ascl1 mutants exhibit more subtle defects in striatal development [14] and, accordingly, showed a more modest reduction in FoxP1 expression (Figure 4C). Interestingly, the Gsx2;Ascl1 double mutants showed an even more severe reduction in FoxP1 staining than the Gsx2 mutants (Figure 4D), indicating that only a rudimentary striatum is present in these brains.
###end p 24
###begin p 25
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 0 100 0 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Removal of <italic>Ascl1 </italic>on the <italic>Gsx2 </italic>mutant background exacerbates the <italic>Gsx2 </italic>mutant phenotype in the striatum</bold>
###xml 102 106 102 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 168 172 168 172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 257 261 257 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 309 320 309 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 445 449 445 449 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 526 532 526 532 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E-G) </bold>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 702 706 702 706 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H) </bold>
###xml 706 717 706 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 799 804 799 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 844 855 844 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1109 1119 1109 1119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I, J, L) </bold>
###xml 1230 1235 1230 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1251 1262 1251 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1282 1286 1282 1286 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K) </bold>
###xml 1286 1292 1286 1292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
Removal of Ascl1 on the Gsx2 mutant background exacerbates the Gsx2 mutant phenotype in the striatum. (A) FoxP1 expression labels striatal projection neurons at E18.5. (B) In Gsx2 mutants, the expression domain of FoxP1 in the striatum is severely reduced. (D) Removal of Ascl1 on the Gsx2 mutant background (Gsx2;Ascl1 double mutant) results in a more severe effect on the FoxP1 expression domain compared to Gsx2 mutants (compare (D) to (B)). (C) Ascl1 mutants display relatively normal expression of FoxP1 in the striatum. (E-G) Gsx2 mutants also exhibit a severe reduction in DARPP-32 expression (F), which is enriched in early born striatal neurons at E18.5 in controls (E) and Ascl1 mutants (G). (H) Gsx2;Ascl1 double mutants display a more severe phenotype in DARPP-32 expression compared to Gsx2 mutants (compare (H) to (F)). Note that Gsx2;Ascl1 double mutants display a complete loss of DARPP-32 positive neurons in the striatum (H). The only DARPP-32 staining observed in the double mutant striatum is in fibers (arrow in (H)), which presumably arise from the cortical DARPP-32 expressing neurons. (I, J, L) Calbindin (CB) expression labels the later born striatal neurons at E18.5 (I) and is upregulated in the SVZ of Gsx2 mutants (J) and Gsx2;Ascl1 double mutants (L). (K) Ascl1 mutants exhibit a noticeable reduction in CB expression in the striatum. ac, anterior commissure.
###end p 25
###begin p 26
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 337 338 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 399 405 399 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 491 502 491 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 601 611 601 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 635 636 635 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 742 743 742 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 795 800 795 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4J</xref>
###xml 886 892 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4K</xref>
###xml 961 972 961 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4L</xref>
###xml 1089 1099 1089 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 1123 1124 1123 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1184 1195 1184 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1199 1209 1199 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 1295 1300 1295 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
The striatum is composed of two anatomically and neurochemically distinct compartments termed the patch and matrix [22]. The striatum-enriched phosphoprotein DARPP-32 has been shown to mark the forming patch compartment at perinatal time points [23] (Figure 4E). DARPP-32 is severely reduced in the Gsx2 mutant striatum (Figure 4F) [1,2,5,24] while its expression was only moderately reduced in the Ascl1 mutants (Figure 4G). Interestingly, no DARPP-32-positive neurons were observed in the Gsx2;Ascl1 double mutant striatum (Figure 4H), a finding that is identical to that previously observed in the Gsx1;Gsx2 double mutant striatum [5]. Calbindin is known to mark the matrix compartment in the mature striatum [22]. As previously reported [5], calbindin expression is increased in the forming Gsx2 mutant striatum (Figure 4J) while a clear reduction in its expression was seen in the Ascl1 mutant striatum (Figure 4K). The rudimentary striatum present in the Gsx2;Ascl1 double mutant striatum did express calbindin (Figure 4L). Again, this was similar to that previously observed in the Gsx1;Gsx2 double mutant striatum [5]. Thus, the similarities in the phenotypes observed in the Gsx2;Ascl1 and Gsx1;Gsx2 double mutants suggest that Ascl1 is required for the Gsx1-based striatal recovery in Gsx2 mutants.
###end p 26
###begin p 27
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 123 134 123 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 251 262 251 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 266 276 266 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 471 482 471 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 508 513 508 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C, F</xref>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 621 626 621 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, E</xref>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
In order to determine whether Ascl1 is required downstream of Gsx1 in a Gsx2 mutant, we examined the expression of Gsx1 in Gsx2;Ascl1 double mutants. If Ascl1 is required for Gsx1 to expand throughout the Gsx2 mutant LGE, then the similarities in the Gsx2;Ascl1 and Gsx1;Gsx2 double mutant phenotypes would be easily explained by the lack of Gsx1 in LGE progenitors. However, this is not the case, because we observed both Gsx1 gene expression and Gsx1/2 staining in the Gsx2;Ascl1 double mutant LGE (Figure 5C, F). Indeed, the level and extent of this expression was very similar to that seen in the Gsx2 mutant (Figure 5B, E). This allows us to conclude that Ascl1 acts downstream of Gsx1 in the Gsx2 mutant LGE.
###end p 27
###begin p 28
###xml 28 39 28 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 expands throughout the <italic>Gsx2;Ascl1 </italic>mutant lateral ganglionic eminence (LGE)</bold>
###xml 81 87 81 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-C) </bold>
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 206 217 206 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 234 240 234 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D-F) </bold>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 481 492 481 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
Gsx1 expands throughout the Gsx2;Ascl1 mutant lateral ganglionic eminence (LGE). (A-C) Gsx1 expression is barely present in the E16.5 wild type LGE (A) but appears to be expressed similarly in Gsx2 (B) and Gsx2;Ascl1 mutant (C) LGEs. (D-F) The Gsx1/2 antibody can be used in Gsx2 mutants to visualize Gsx1 protein expression and not only is gene expression expanded in the mutants compared to wild type (D) but Gsx1 protein is found in a similar pattern in the Gsx2 mutant (E) and Gsx2;Ascl1 mutant (F) LGEs. The Gsx1/2 staining in the wild type mostly reflects Gsx2 expression since very little Gsx1 expression in seen in the wild type LGE (A).
###end p 28
###begin title 29
###xml 26 37 26 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
Olfactory bulb defects in Gsx2;Ascl1 double mutants
###end title 29
###begin p 30
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 774 779 774 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A, E</xref>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 902 907 902 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B, F</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 924 930 924 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1224 1226 1224 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 1307 1313 1307 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1424 1426 1424 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G</xref>
###xml 1448 1459 1448 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1534 1539 1534 1539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1555 1560 1555 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B, D</xref>
###xml 1657 1659 1657 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H</xref>
Unlike striatal neurons that are largely produced at embryonic stages, olfactory bulb interneurons are generated over a protracted period, starting around E14 and with the majority produced during the first 2 weeks after birth [25]. Since Gsx2 mutants die shortly after birth [4], only the olfactory bulb interneurons that are generated at embryonic stages can be assayed. Previous studies [1,3,5,6] have shown that Gsx2 mutants exhibit defects in the development of these neurons at birth. The olfactory bulb interneurons produced at embryonic time points have been suggested to originate, at least in part, from the dorsal (d)LGE [26]. We have recently shown that the zinc finger transcription factor Sp8 marks the dLGE as well as olfactory bulb interneurons [27] (Figure 6A, E). In Gsx2 mutants, the number of Sp8 expressing cells is dramatically reduced in both the dLGE and olfactory bulb (Figure 6B, F) [27]. Although Ascl1 mutants have been shown to have olfactory bulb interneuron defects [14,28], the expression of Sp8 in these mutants is not reduced in the dLGE at E15.5 [17]; rather, it appears as if more cells are seen in this region streaming laterally towards the ventrolateral telencephalon by E18.5 (Figure 6C). Moreover, there appear to be similar numbers of Sp8-positive cells within the Ascl1 mutant olfactory bulb compared to wild type, although their distribution appears somewhat disorganized (Figure 6G). Conversely, in the Gsx2;Ascl1 double mutants the expression of Sp8 is reduced, even when compared to the Gsx2 mutants (Figure 6B, D). Indeed, most sections of the double mutant olfactory bulb lack any Sp8-positive cells (Figure 6H).
###end p 30
###begin p 31
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 0 173 0 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Gsx2;Ascl1 </italic>double mutants exhibit a more severe phenotype in the formation of the dorsal lateral ganglionic eminence (dLGE) and the generation of olfactory bulb interneurons</bold>
###xml 175 182 175 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A, B) </bold>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 277 281 277 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 281 292 281 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 410 414 410 414 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 414 420 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 516 523 516 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E, F) </bold>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 623 627 623 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H) </bold>
###xml 627 638 627 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 718 722 718 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) </bold>
###xml 752 758 752 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
Gsx2;Ascl1 double mutants exhibit a more severe phenotype in the formation of the dorsal lateral ganglionic eminence (dLGE) and the generation of olfactory bulb interneurons. (A, B) The Sp8 expression domain in the dLGE is reduced in Gsx2 mutants (B) compared to controls (A). (D) Gsx2;Ascl1 double mutants exhibit a more severe reduction in the expression of Sp8 in the dLGE (D) compared to Gsx2 mutants (B). (C) Ascl1 mutants maintain Sp8 expression in the dLGE and may have a slightly expanded expression domain. (E, F) Sp8 expressing interneurons are reduced in Gsx2 mutant olfactory bulb (F) compared to controls (E). (H) Gsx2;Ascl1 mutant displays nearly a complete loss of Sp8 expression in the olfactory bulb. (G) Sp8 expression is observed in Ascl1 mutant olfactory bulbs, but in a slightly disorganized pattern (compare (G) to (E)). gl, glomerular layer.
###end p 31
###begin p 32
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 648 653 648 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B, F</xref>
###xml 666 672 666 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7G</xref>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 872 883 872 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 974 979 974 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D, H</xref>
###xml 1000 1001 1000 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 1002 1003 1002 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1004 1005 1004 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1006 1007 1006 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1031 1036 1031 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7J</xref>
###xml 1052 1058 1052 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1074 1076 1074 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7K</xref>
###xml 1141 1143 1141 1143 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67</sub>
###xml 1186 1189 1186 1189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67 </sub>
###xml 1273 1284 1273 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1323 1325 1323 1325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67</sub>
###xml 1404 1406 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7L</xref>
###xml 1449 1455 1449 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1479 1484 1479 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1569 1574 1569 1574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1668 1674 1668 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1715 1718 1715 1718 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67 </sub>
###xml 1770 1772 1770 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
Sp8 is required for normal development of the calretinin (CR)-expressing subtype of olfactory bulb interneurons [27]. In addition to the dLGE, the septum has also been suggested to give rise to olfactory bulb interneurons [29], and more recent results suggest that the septum may also represent a region where the CR interneurons originate [30,31]. Indeed, CR positive neurons can be seen in the wild-type dLGE and even more so in the septum at E18.5 (Figure 7A) as well as in the forming glomerular layer of the olfactory bulb (Figure 7E). As might be predicted from the Sp8 staining, the Gsx2 mutants showed reductions in CR interneurons (Figure 7B, F), while the Ascl1 mutants did not appear to exhibit reduced numbers of CR positive cells (Figure 7G) and at least in portions of the dLGE may even contain increased numbers of these cells (Figure 7C). Furthermore, the Gsx2;Ascl1 double mutants showed a more severe reduction in CR staining than the Gsx2 mutants (Figure 7D, H). Previous studies [1,3,5,6,14,28] have shown that Gsx2 (Figure 7J) and Ascl1 mutants (Figure 7K) exhibit reductions in glutamic acid decarboxylase (67 kDa) (GAD67)-positive olfactory bulb interneurons (GAD67 is a rate limiting enzyme in GABA production). These appear to be compounded in the Gsx2;Ascl1 double mutants where essentially no GAD67-positive cells were observed in the olfactory bulb at this time point (Figure 7L). Taken together, these data suggest that Ascl1 functions downstream of Gsx2 to regulate aspects of olfactory bulb interneuron diversity. Indeed, it appears that Gsx2 is required for many, if not all, of the interneuron subtypes to be properly generated, while Ascl1 is more crucial for the generation of GAD67 (that is, GABAergic) and dopaminergic interneurons [28].
###end p 32
###begin p 33
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 68 79 68 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Olfactory bulb interneuron subtype specification in <italic>Gsx2</italic>, <italic>Ascl1 </italic>and <italic>Gsx2;Ascl1 </italic>mutants</bold>
###xml 88 94 88 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-H) </bold>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 232 243 232 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 343 354 343 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 436 442 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 473 480 473 480 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(J, L) </bold>
###xml 483 486 483 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67 </sub>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 595 606 595 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 619 626 619 626 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I, K) </bold>
###xml 694 697 694 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67 </sub>
Olfactory bulb interneuron subtype specification in Gsx2, Ascl1 and Gsx2;Ascl1 mutants. (A-H) Calretinin (CR) staining in the dLGE (A-D) and olfactory bulb (E-H) in E18.5 wildtype (A, E), Gsx2 mutant (B, F), Ascl1 mutant (C, G) and Gsx2;Ascl1 mutants (D, H). Note that CR cells in the dLGE and olfactory bulb are severely depleted in Gsx2 and Gsx2;Ascl1 mutants while there appear to be similar if not more numbers of CR neurons in the Ascl1 mutants compared to wild type. (J, L) GAD67 (glutamic acid decarboxylase (67 kDa)) staining is severely reduced in Gsx2 mutants (J) and nearly absent in Gsx2;Ascl1 mutants (L). (I, K) In comparison, Ascl1 mutants (K) show a more modest reduction in GAD67 staining but it is still quite severe when compared to the wild-type olfactory bulb (I). GCL, granule cell layer; GL, glomerular layer.
###end p 33
###begin title 34
###xml 19 30 19 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
Notch signaling in Gsx2;Ascl1 double mutants
###end title 34
###begin p 35
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 234 245 234 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8F</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 602 603 602 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8J</xref>
###xml 736 741 736 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8N</xref>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 820 826 820 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E</xref>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8G</xref>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8K</xref>
###xml 1121 1126 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8O</xref>
###xml 1184 1186 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1213 1224 1213 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1330 1335 1330 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 1343 1345 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8L</xref>
###xml 1351 1356 1351 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
###xml 1364 1366 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8P</xref>
###xml 1449 1455 1449 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1524 1530 1524 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1705 1710 1705 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1752 1758 1752 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1816 1821 1816 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 1839 1850 1839 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1969 1971 1969 1971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 2036 2041 2036 2041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C, F</xref>
Previous studies have shown that Notch signaling is required for normal LGE/striatal development [16,32]. Moreover, Ascl1 mutants exhibit reduced Notch signaling [14,16]. It is possible, therefore, that the phenotypes observed in the Gsx2;Ascl1 double mutants are a result of compound effects of a loss of Notch signaling together with distinct Gsx2 requirements. To address this, we examined the expression of factors in the Notch signaling pathway, Ngn2, Dll1 and Hes5, in relation to Gsx1/2 expression. In Gsx2 mutants, Ngn2 was shifted ventrally into the LGE as previously described (Figure 8F) [1-3], although it appeared to be directly abutting the ventrally shifted Gsx1/2 staining (Figure 8B). Indeed, both Dll1 (Figure 8J) and Hes5 (Figure 8N) were continuously expressed throughout the Gsx2 mutant LGE. In the Ascl1 mutants, Gsx1/2 staining was present up to the normal pallio-subpallial boundary (Figures 3A and 8C) and Ngn2 staining abutted it at its normal ventral position (compare Figure 8E and 8G). This theoretically leaves no proneural gene expression in the LGE and, in fact, both Dll1 (Figure 8K) and Hes5 (Figure 8O) staining was absent, as previously described [14]. This is not the case in Gsx2;Ascl1 double mutants, where Ngn2 was observed to extend ventrally into the double mutant LGE and improvement in Dll1 (Figure 8L) and Hes5 (Figure 8P) expression was observed, at least within the presumptive LGE region, compared to Ascl1 mutants. This indicates that the Notch signaling defects observed in Ascl1 mutants are, in part, due to Gsx2 expression remaining in the LGE. Thus, it appears that Ascl1 performs a non-proneural function in the Gsx1-mediated recovery observed in the Gsx2 mutant. Interestingly, it also seems that Ascl1 plays a role in the timing of the Gsx1 expansion into the Gsx2 mutant LGE as the Gsx2;Ascl1 double mutants showed much less Gsx1 (as marked by Gsx1/2 staining) expression in the presumptive LGE at E12.5 (Figure 8D) when compared to later time points (for example, E16.5; Figure 5C, F).
###end p 35
###begin p 36
###xml 60 71 60 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Notch signaling in the lateral ganglionic eminence (LGE) of <italic>Gsx2;Ascl1 </italic>mutants is improved from that in <italic>Ascl1 </italic>mutants</bold>
###xml 119 122 119 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A)</bold>
###xml 185 192 185 192 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, C) </bold>
###xml 249 254 249 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 392 396 392 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 439 450 439 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 526 536 526 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E, F, H) </bold>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 636 647 636 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 759 763 759 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) </bold>
###xml 816 822 816 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 886 892 886 892 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I-P) </bold>
###xml 959 964 959 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 968 972 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5</italic>
###xml 989 994 989 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 1002 1007 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
###xml 1179 1184 1179 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 1192 1197 1192 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
###xml 1244 1250 1244 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1366 1377 1366 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1397 1402 1397 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 1410 1415 1410 1415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
Notch signaling in the lateral ganglionic eminence (LGE) of Gsx2;Ascl1 mutants is improved from that in Ascl1 mutants. (A)_Gsx1/2 staining in the E12.5 wild type ventral telencephalon. (B, C) Gsx1/2 staining illustrates the expansion of Gsx1 in the Gsx2 mutant LGE (B) as well as the expression of Gsx proteins in the Ascl1 mutant LGE (C); arrows point to the dorsal limit of Gsx expression. (D) Note that the Gsx1 expansion is delayed in Gsx2;Ascl1 mutants at this stage but, as shown earlier, this recovers at later stages. (E, F, H) The proneural protein Ngn2 is normally expressed in pallial progenitors (E) but in the Gsx2 (F) and Gsx2;Ascl1 mutants (H) the ventral limit of Ngn2 expression (arrows in (F, H)) has expanded ventrally into the mutant LGE. (G) In contrast, the ventral limit of Ngn2 expression in Ascl1 mutants (arrow) appears to be similar to that in wild type (E). (I-P) The status of Notch signaling can be assessed by the expression of Dll1 and Hes5. In wild types, Dll1 (I) and Hes5 (M) are expressed in ventricular zone (VZ) progenitors along the dorsal-ventral axis of the telencephalon. As is the case in the wild types, Gsx2 mutants appear to express Dll1 (J) and Hes5 (N) throughout the telencephalic VZ, while the Ascl1 mutants exhibit expression only in the dorsal telencephalon (K, O) corresponding with Ngn2 expression. Although the Gsx2;Ascl1 mutants do not show Dll1 (L) and Hes5 (P) expression in the ventral-most telencephalon (that is, medial ganglionic eminence (MGE) remnant indicated by asterisk) these Notch effectors are expressed in the mutant LGE progenitors unlike the case in Ascl1 mutants. Asterisks in (C, D, G, H, K, L, O, P) indicate the remnant of the MGE.
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 435 440 435 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 464 465 464 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 788 799 788 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 847 857 847 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 866 867 866 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 868 869 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 900 911 900 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 956 961 956 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 987 993 987 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1019 1024 1019 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 1081 1086 1081 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1</italic>
###xml 1101 1106 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1</italic>
###xml 1198 1203 1198 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1206 1208 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1209 1211 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1351 1356 1351 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
The study of knock-out mice is essentially an investigation into the compensatory mechanisms (or lack thereof) when any given gene is inactivated. In the case of Gsx2, it has previously been shown that Gsx1 is involved in the partial recovery observed in these mutants [5,6]. What remained unclear was why the Gsx1-dependent compensation was not more effective in restoring normal development. In addition to a delayed upregulation of Gsx1 in the Gsx2 mutant LGE [5,6], we provide novel data here showing that Gsx1 is expressed only in a subset of LGE cells that would normally express Gsx2. Interestingly, these cells are largely located at the boundary between the VZ and SVZ, similar in location to that of Ascl1 expressing cells. Based on the facts that the striatal phenotype of the Gsx2;Ascl1 mutants is nearly identical to that observed in Gsx1;Gsx2 mutants [5,6] and that Gsx1 expands in the Gsx2;Ascl1 mutants in a similar way to that observed in Gsx2 mutants, we conclude that Ascl1 is required downstream of Gsx1 for this recovery. These findings suggest that there are Ascl1-dependent and Ascl1-independent pathways for LGE development. This is in agreement with recent studies by Long et al. [17,19] showing that Dlx1/2 and Ascl1 regulate parallel and overlapping pathways in LGE specification. Furthermore, our results indicate that the Ascl1-dependent pathway for LGE specification appears to be independent of its well-known role in regulating the Notch signaling pathway.
###end p 38
###begin p 39
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 270 275 270 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 860 861 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 862 863 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
The mechanism by which Gsx1 is upregulated in the Gsx2 mutant LGE has been unclear. It does not appear that Gsx2 represses Gsx1 expression because only a subset of the cells that normally express Gsx2, particularly those at the VZ/SVZ boundary, are Gsx1-positive in the Gsx2 mutant LGE. It seems possible, therefore, that Gsx1 can only be expressed in certain cell types or in cells that have reached a particular level of maturation (that is, cells transitioning from the VZ to the SVZ). Indeed, it appears that Gsx1-positive cells in the medial ganglionic eminence region also reside largely in the VZ/SVZ boundary region (for example, Figure 2C). Interestingly, at early stages (that is, E12.5) in the Gsx2 mutants, the LGE SVZ does not form, and only after Gsx1 has expanded throughout the mutant LGE (that is, by E14-15) does the it do so in this mutant [2,3,5]. Together with the current findings, these results suggest that Gsx1 may be expressed in more mature progenitors and might even play a role in the maturation process.
###end p 39
###begin p 40
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 503 504 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1</italic>
###xml 621 626 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 742 752 742 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1;Gsx2 </italic>
###xml 768 769 768 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 770 771 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 780 786 780 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 818 822 818 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1</italic>
###xml 853 858 853 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 913 914 913 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 915 916 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1081 1082 1081 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1083 1084 1083 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1215 1226 1215 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
Ascl1 has previously been implicated in the development of the striatum and olfactory bulb interneurons [14-17,28]. In general, however, the requirement for Ascl1 in striatal and olfactory bulb development is not as great as that for Gsx2. In fact, the striatum of the Ascl1 mutant is only slightly reduced in size when compared to the wild type [14] (Figure 4). Moreover, the reduction in dopaminergic and GABAergic olfactory bulb interneurons [28] is not as severe as that observed in Gsx2 mutants [5,6]. Although striatal development is only modestly affected by the loss of Ascl1, we show here that the added loss of Gsx2 results in a nearly complete loss of striatal development. This result is identical to that previously reported for Gsx1;Gsx2 double mutants [5,6]. Thus, Ascl1 is absolutely essential for the Gsx1-mediated recovery observed in Gsx2 mutants. While Ascl1 appears to be downstream of Gsx2 [1-3], the relationship between Gsx1 and Ascl1 appears to be more complex. The loss of Gsx1 and Gsx2 severely depletes the expression of Ascl1 throughout embryogenesis [5,6], suggesting that both are genetically upstream; however, our findings here also demonstrate a delay in the expression of Gsx1 in Gsx2;Ascl1 double mutants at early stages (for example, Figure 8D), potentially implicating Ascl1 in feedback regulation of Gsx1 expression.
###end p 40
###begin p 41
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 221 232 221 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 475 486 475 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 513 519 513 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 570 581 570 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2;Ascl1 </italic>
###xml 604 609 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
Ascl1 is a known regulator of the Notch signaling pathway [14,16] and Notch signaling has previously been implicated in controlling striatal development [16,32]. It does not seem that the striatal defects observed in the Gsx2;Ascl1 double mutants, described here, are simply due to compound effects of the loss of Gsx2 and impaired Notch signaling because we observed an improvement in Notch signaling (as indicated by Hes5 and Dll1 expression) within LGE progenitors of the Gsx2;Ascl1 double mutants compared to Ascl1 mutants. Our interpretation of this result is that Gsx2;Ascl1 mutants are similar to Gsx2 mutants in that Ngn2 is allowed to expand ventrally into the LGE and, as a result, Notch signaling is improved. Clearly, Ascl1 plays a role in regulating Notch signaling within LGE progenitors [14,16]; however, the fact that striatal development is not more severely affected in the Ascl1 mutant could suggest that Gsx2 normally works through another gene encoding a basic helix-loop-helix (bHLH) factor to regulate aspects of LGE neurogenesis.
###end p 41
###begin p 42
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 324 330 324 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
A somewhat surprising finding that we observed in the Ascl1 mutants was that Gsx2 expression appeared to be increased at perinatal stages. This is not the case at early time points (for example, E12.5) and suggests that Ascl1 may play a role in depleting the Gsx2 progenitors during embryogenesis. The increased Gsx2 in the Ascl1 mutant LGE correlated well with the expression of Sp8, a zinc finger transcription factor that has previously been shown to be dependent on Gsx2 expression [27].
###end p 42
###begin p 43
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 643 645 643 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67</sub>
###xml 693 699 693 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 911 917 911 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
Previous studies have described a reduction in dopaminergic and GABAergic interneurons in the Ascl1 mutants [14,28]; however, no data on other subtypes have been provided. We show here that unlike the dopaminergic and GABAergic subtypes, the CR interneurons are not reduced and may, in fact, be increased. The neurotransmitter of this subtype remains somewhat unclear. Recent reports suggests that as few as 14% are GABAergic [33], while others suggest that most if not all are GABAergic [30,34]. Our data seem to support the former possibility (at least at this stage of development) since the reduction in GABAergic neurons (as marked by GAD67) is not paralleled by CR-positive cells in the Ascl1 mutant olfactory bulb. We have recently shown that the zinc finger transcription factor Sp8 is required for the normal development of the CR interneurons in the olfactory bulb [27]. Accordingly, we found that in Ascl1 mutants at late stages of development, Sp8 staining is maintained in the dLGE and olfactory bulbs. Because Gsx2 is required for Sp8 expression in the dLGE and the latter is essential for normal CR interneuron production, it seems likely that the sequential expression of these two transcription factors cooperate to generate this interneuron subtype. However, despite that Gsx2 appears to function upstream of Ascl1, this bHLH factor does not actively promote CR interneuron development.
###end p 43
###begin p 44
###xml 126 131 126 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 427 432 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 655 660 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 821 827 821 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 1312 1317 1312 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 1320 1322 1320 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1478 1479 1478 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1558 1559 1558 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
The origin of distinct subtypes of olfactory bulb interneurons has recently been the subject of considerable attention. Kohwi et al. [30] have recently suggested that CR interneurons arise from pallial and septal regions but not the dLGE. On the other hand, De Marchis et al. [35] found that these interneurons were generated from the postnatal region of the SVZ that directly derives from the dLGE. In support of this, Merkle et al. [31] showed that at least some CR neurons are derived from the rostral dorsal SVZ (a likely derivative of the dLGE). Although CR interneurons start to be produced at embryonic time points, a recent study by Batista-Brito et al. [36] have shown that most are generated at postnatal time points. Our data show that at least a few CR neurons are present in the late embryonic dLGE and that Ascl1 mutants appear to exhibit enhanced CR neuron production in the dLGE and possibly olfactory bulb. Thus, Ascl1 may play a role in the temporal regulation of CR interneuron production from the dLGE and its SVZ derivatives. In any case, our findings clearly demonstrate that the dLGE is a significant source of CR interneurons that are generated at embryonic time points; however, we cannot exclude the contribution of the septum in the generation of these interneurons as shown by Merkle et al. [31], particularly at early postnatal stages. Indeed, Gsx2 is expressed at high levels in both the dLGE as well as in the dorsal portion of the septum (Figure 2) and CR staining in the septal region is also lost in the Gsx2 mutant (Figure 7). Regardless of their origin, it seems that all subtypes of olfactory bulb interneurons, at least at embryonic time points, require Gsx2 for their normal production.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
Our data show that Gsx1 compensates for the loss of Gsx2 gene function in only a subpopulation of the LGE progenitors that normally express Gsx2, which may explain why the compensation is not more complete. Additionally, we show that Ascl1 is an obligate factor for Gsx1 in the recovery process and that this is independent of its well-known proneural function.
###end p 46
###begin title 47
Methods
###end title 47
###begin p 48
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 20 22 20 22 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 69 70 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 153 164 153 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1;Gsx2 </italic>
###xml 230 241 230 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1;Gsx2 </italic>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Gsx2 [4] and Ascl1 [37] mice were genotyped as previously described [2,14]. Interbreeding between Gsx2 and Ascl1 heterozygotes was performed to generate Ascl1;Gsx2 double heterozygotes, which were subsequently crossed to generate Ascl1;Gsx2 double homozygous mutants.
###end p 48
###begin p 49
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 4 9 4 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 161 164 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 240 245 240 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 461 466 461 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 488 491 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe</italic>
###xml 516 521 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 571 574 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpa</italic>
###xml 651 654 651 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 659 662 659 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 687 692 687 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 742 745 742 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 843 846 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Afl</italic>
###xml 879 882 879 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nhe</italic>
###xml 967 970 967 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 1002 1005 1002 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spe</italic>
###xml 1065 1068 1065 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1117 1120 1117 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pme</italic>
###xml 1164 1168 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 1168 1173 1168 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 1168 1173 1168 1173 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 1200 1203 1200 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 1270 1272 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1371 1376 1371 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A, B</xref>
###xml 1468 1472 1468 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 1472 1476 1472 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 1472 1479 1472 1479 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 1768 1772 1768 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 1772 1776 1772 1776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 1772 1779 1772 1779 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 2039 2043 2039 2043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 2043 2047 2043 2047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 2043 2050 2043 2050 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+ </sup>
###xml 2068 2084 2068 2081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin-FLPe </italic>
###xml 2108 2110 2105 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 2271 2273 2268 2270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A</xref>
###xml 2297 2301 2294 2298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 2301 2305 2298 2302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 2301 2307 2298 2304 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/+</sup>
###xml 2682 2684 2679 2681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C</xref>
###xml 2758 2761 2755 2758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 2790 2794 2787 2791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 2794 2798 2791 2795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP</italic>
###xml 2799 2804 2796 2801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 2794 2804 2791 2801 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP</italic>/<italic>EGFP </italic></sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 1877 1885 <span type="species:ncbi:9606">Children</span>
###xml 2003 2007 <span type="species:ncbi:10090">mice</span>
###xml 2050 2054 <span type="species:ncbi:10090">mice</span>
###xml 2102 2106 <span type="species:ncbi:10090">mice</span>
Gsx2EGFP knock-in mice were generated by inserting an IRES-EGFP-pA cassette (Clonetech, Mountain View, CA, USA) into the first exon of Gsx2 between the NotI and NcoI sites (Figure 9A). Specifically, a 9-kb genomic fragment encompassing the Gsx2 locus was isolated by a HindIII digest of a Gsx2-positive 129 BAC and subcloned into the HindIII site of pBluescript SK (Stratagene, La Jolla, CA, USA). The targeting vector backbone was previously described in Bell et al. [38]. A 6.4-kb Nco1/Spe1 fragment from the 9-kb Gsx2 genomic region was blunted and subcloned into the Hpa1 site of cre/lox targeting vector to be used as the 3' homology arm. A 1-kb HindIII/Not1 fragment from the 9-kb Gsx2 genomic region was blunted and subcloned into the Sma1 site of pBluescript SK (called 5'arm-PBS). The pIRES2-EGFP vector (Clonetech) was digested with AflII, blunted, and redigested with Nhe1 to release IRES-EGFP. IRES-EGFP was cloned into 5'arm-PBS, which was digested with Sal1, blunted, and redigested with Spe1 (5'arm-EGFP-PBS). The 5'arm-IRES-EGFP was released with a Xho1 digest that was blunted and subcloned into the Pme1 site of the cre/lox targeting vector. The Gsx2EGFP vector was linearized with Sal1 and electroporated in W4 embryonic stem (ES) cells (reviewed in [39]) and selected with G418 and gancyclovir. Correctly targeted cells were identified by PCR (Figure 9A, B) using the following primer pairs to generate products specific for the correctly targeted Gsx2EGFP/+ allele: internal primer 1 (5'-cctccgcttctgttgtgact-3') with internal primer 2 (5'-cctaggaatgctcgtcaagaag-3'), which gave an 837 bp product, and an external primer (5'-cctccactacaaggccacatac3') with internal primer 2, which generated a 1,170 bp product, specific for the correctly targeted Gsx2EGFP/+ allele. Two different targeted ES cell lines were used for blastocyst injection by the Cincinnati Children's Hospital Medical Center transgenic facility. Germline transmission was tested by crossing the chimeras with C57/B6 mice to obtain agouti offspring. F1 Gsx2EGFP/+ mice were bred to beta-actin-FLPe (enhanced Flpase) mice [40] obtained from Jackson Laboratory, Bar Harbor, ME, which resulted in the Neomyocin cassette flanked by FLP recombinase target (FRT) sites to be removed (Figure 9A). Embryos derived from Gsx2EGFP/+crosses were genotyped with the following primers: internal 2 (5'-cctaggaatgctcgtcaagaag-3') with Gsx2 int5A (5'-catcaccatcaccagcccc-3'), which generated a 225 bp product specific for the knock-in allele; and Gsx2-Int5B (5'-ccacggagattccactgcc 3') with Gsx2-1437 (5'-gcatccaccccaaatctcagtc-3'), which generated a 298 bp product specific for the Gsx2 wild-type allele (Figure 9C). The Gsx2-Int5b primer binds in the deleted region of exon 1 before the Nco1 site so homozygous mutants Gsx2EGFP/EGFP do not have a wild-type band.
###end p 49
###begin p 50
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 37 42 37 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Targeting scheme to generate the <italic>Gsx2</italic><sup><italic>EGFP </italic></sup>knock-in allele</bold>
###xml 59 63 59 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 231 234 231 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nco</italic>
###xml 240 243 240 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 510 515 510 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 510 515 510 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 637 639 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 648 652 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 652 657 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 652 657 649 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 709 713 706 710 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 820 824 817 821 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 874 878 871 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 878 883 875 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 878 883 875 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 900 905 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2 </italic>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
Targeting scheme to generate the Gsx2EGFP knock-in allele. (A) Using homologous recombination in embryonic stem cells an IRES-enhanced green fluorescent protein (EGFP) cassette was inserted in the first exon of the Gsx2 between an Nco1 and Not1 site. This removed 125 bp of the coding region of the first exon but left the exon-intron structure intact. The polyA signal at the end of the IRES-EGFP cassette effectively terminated the message and, as shown in Figure 1, no Gsx2 protein is observed when the Gsx2EGFP allele is bred to homozygosity. The Neomycin (Neo) cassette was removed by breeding the mice with beta-actin-Flpase mice [38]. These Gsx2EGFP minus Neo mice were exclusively used in this study. (B) Correctly targeted embryonic stem cells were identified using the primers indicated as half arrows in (A). (C) Embryos are genotyped using primers to detect the Gsx2EGFP allele and using Gsx2 primers that include one sequence in the deleted region of the first exon. M, DNA marker; pd, primer dimmer.
###end p 50
###begin p 51
###xml 416 419 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
For staging of embryos, the morning of vaginal plug detection was designated as E0.5. At least three embryos of each genotype were examined for every stage studied and marker used. Embryos were fixed overnight in 4% paraformaldehyde at 4degreesC, rinsed extensively in phosphate-buffered saline and cryoprotected in 30% sucrose before sectioning at 12-14 mum on a cryostat. Sections were thaw-mounted onto SuperFrost(R)/Plus slides (Fisher Scientific, Pittsburgh, PA, USA) and stored at -20degreesC until used.
###end p 51
###begin p 52
###xml 387 390 387 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67 </sub>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 88 94 <span type="species:ncbi:9986">rabbit</span>
###xml 147 153 <span type="species:ncbi:9986">rabbit</span>
###xml 201 205 <span type="species:ncbi:9925">goat</span>
###xml 264 270 <span type="species:ncbi:9986">rabbit</span>
###xml 319 325 <span type="species:ncbi:9986">rabbit</span>
###xml 372 378 <span type="species:ncbi:9986">rabbit</span>
###xml 412 416 <span type="species:ncbi:9925">goat</span>
###xml 464 470 <span type="species:ncbi:9986">rabbit</span>
###xml 497 503 <span type="species:ncbi:9986">rabbit</span>
###xml 551 557 <span type="species:ncbi:9986">rabbit</span>
###xml 606 612 <span type="species:ncbi:9986">rabbit</span>
###xml 658 664 <span type="species:ncbi:9986">rabbit</span>
###xml 757 762 <span type="species:ncbi:9823">swine</span>
###xml 768 774 <span type="species:ncbi:9986">rabbit</span>
###xml 836 841 <span type="species:ncbi:9796">horse</span>
###xml 847 851 <span type="species:ncbi:9925">goat</span>
###xml 1122 1128 <span type="species:ncbi:9793">donkey</span>
###xml 1134 1138 <span type="species:ncbi:9925">goat</span>
###xml 1219 1225 <span type="species:ncbi:9793">donkey</span>
###xml 1231 1237 <span type="species:ncbi:9986">rabbit</span>
For immunohistochemistry, primary antibodies were used at the following concentrations: rabbit anti-Ascl1 (Mash1; 1:1,000; provided by J Johnson); rabbit anti-calbindin (1:2,500; provided by P Emson); goat anti-calretinin (1:2,000; Millipore, Billerica, MA, USA); rabbit anti-Dll (pan DLX; 1:400; provided by J Khotz); rabbit anti-FoxP1 (1:4,000; provided by E Morissey); rabbit anit-GAD67 (1:1,000; Millipore); goat anti-GFP (1:5,000; Abcam, Cambridge, MA, USA); rabbit anti-Gsx2 (1:5,000; [2]); rabbit anti-Gsx1/2 (1:2,000; provided by M Goulding); rabbit anti-Ki67 (1:1,000; Novocastra, Newcastle, UK); rabbit anti-Ngn2 (1:1,000; provided by M Nakafuku); rabbit anti-Sp8 (1:500; [26]). The secondary antibodies for brightfield staining were biotinylated swine anti-rabbit antibodies (1:200; DAKO, Glostrup, Denmark) and biotinylated horse anti-goat antibodies (1:200; Vector Laboratories, Burlingame, CA, USA). For visualization, the ABC kit (Vector Laboratories) followed by diaminobenzidine (DAB; Sigma, St. Louis, MO, USA) as the final chromogen were utilized. The secondary antibodies for fluorescent staining were donkey anti-goat antibodies conjugated to Cy2 (Jackson Immunoresearch, West Grove, PA, USA), and donkey anti-rabbit antibodies conjugated to Cy3 (Jackson Immunoresearch).
###end p 52
###begin p 53
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx1 </italic>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hes5 </italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dll1 </italic>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
In situ hybrization histochemistry was performed using digoxygenin-labeled cRNA probes as described in Toresson et al. [41]. Probes used were Gsx1 [5], Hes5 and Dll1 [14].
###end p 53
###begin title 54
Abbreviations
###end title 54
###begin p 55
###xml 171 173 171 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">67</sub>
bHLH: basic helix-loop-helix; CR: calretinin; E: embryonic day; ES: embryonic stem; dLGE: dorsal lateral ganglionic eminence; EGFP: enhanced green fluorescent protein; GAD67: glutamic acid decarboxylase (67 kDa); LGE: lateral ganglionic eminence; SVZ: subventricular zone; VZ: ventricular zone.
###end p 55
###begin title 56
Competing interests
###end title 56
###begin p 57
The authors declare that they have no competing interests.
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 21 26 21 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsx2</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EGFP </italic>
###xml 117 122 117 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>EGFP </italic></sup>
###xml 206 212 206 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl1 </italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
BW generated the Gsx2EGFP mice and carried out most of the experiments. RRW helped generate and characterize the Gsx2EGFP mice. ZJA helped with some of the immunohistochemistry experiments. FG provided the Ascl1 mice and helped conceive the experiments. KC supervised the studies and wrote the manuscript. All authors read and commented on the manuscript.
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
We gratefully acknowledge the kind gifts of antibodies and probes from P Emson, M Goulding, J Johnson, J Kohtz, E Morrisey and M Nakafuku. This work was supported by the NIH grants NS044080 and MH069643 to KC and by the HFSPO grant RG160-2000B to FG and KC. RRW is supported by an NIH training grant (HD046387) and ZJA is supported by an NIH NRSA (DC008928).
###end p 61
###begin article-title 62
The Gsh2 homeodomain gene controls multiple aspects of telencephalic development
###end article-title 62
###begin article-title 63
Genetic control of dorsal-ventral identity in the telencephalon: opposing roles for Pax6 and Gsh2
###end article-title 63
###begin article-title 64
Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon
###end article-title 64
###begin article-title 65
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Altered forebrain and hindbrain development in mice mutant for the Gsh-2 homeobox gene
###end article-title 65
###begin article-title 66
###xml 77 81 <span type="species:ncbi:10090">mice</span>
A role for Gsh1 in the developing striatum and olfactory bulb of Gsh2 mutant mice
###end article-title 66
###begin article-title 67
Patterning of the lateral ganglionic eminence by the Gsh1 and Gsh2 homeobox genes regulates striatal and olfactory bulb histogenesis and the growth of axons through the basal ganglia
###end article-title 67
###begin article-title 68
The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence
###end article-title 68
###begin article-title 69
Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence
###end article-title 69
###begin article-title 70
Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence
###end article-title 70
###begin article-title 71
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In utero </italic>
In utero fate mapping reveals distinct migratory pathways and fates of neurons born in the mammalian basal forebrain
###end article-title 71
###begin article-title 72
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Gsh-1: a novel murine homeobox gene expressed in the central nervous system
###end article-title 72
###begin article-title 73
Mutations of the homeobox genes Dlx-1 and Dlx-2 disrupt the striatal subventricular zone and differentiation of late born striatal neurons
###end article-title 73
###begin article-title 74
An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons
###end article-title 74
###begin article-title 75
Mash1 regulates neurogenesis in the ventral telencephalon
###end article-title 75
###begin article-title 76
Correct coordination of neuronal differentiation events in ventral forebrain requires the bHLH factor MASH1
###end article-title 76
###begin article-title 77
Modulation of the notch signaling by Mash1 and Dlx1/2 regulates sequential specification and differentiation of progenitor cell types in the subcortical telencephalon
###end article-title 77
###begin article-title 78
Dlx-dependent and - independent regulation of olfactory bulb interneuron differentiation
###end article-title 78
###begin article-title 79
Gsh2 is required for the repression of Ngn1 and specification of dorsal interneuron fate in the spinal cord
###end article-title 79
###begin article-title 80
Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways
###end article-title 80
###begin article-title 81
Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain
###end article-title 81
###begin article-title 82
Expression of Foxp2, a gene involved in speech and language, in the developing and adult striatum
###end article-title 82
###begin article-title 83
The neostriatal mosaic: multiple levels of compartmental organization
###end article-title 83
###begin article-title 84
###xml 121 124 <span type="species:ncbi:10116">rat</span>
Development of a dopamine - and cyclic adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation
###end article-title 84
###begin article-title 85
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
The homeobox gene Gsh2 is required for retinoid production in the embryonic mouse telencephalon
###end article-title 85
###begin article-title 86
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Autoradiographic study of histogenesis in the mouse olfactory bulb. I. Time of origin of neurons and neuroglia
###end article-title 86
###begin article-title 87
Identification of two distinct progenitor populations in the lateral ganglionic eminence: implications for striatal and olfactory bulb neurogenesis
###end article-title 87
###begin article-title 88
The zinc finger transcription factor Sp8 regulates the generation and diversity of olfactory bulb interneurons
###end article-title 88
###begin article-title 89
Mash1 specifies neurons and oligodendrocytes in the postnatal brain
###end article-title 89
###begin article-title 90
DLX5 regulates development of peripheral and central components of the olfactory system
###end article-title 90
###begin article-title 91
A subpopulation of olfactory bulb GABAergic interneurons is derived from Emx1- and Dlx5/6-expressing progenitors
###end article-title 91
###begin article-title 92
Mosaic organization of neural stem cells in the adult brain
###end article-title 92
###begin article-title 93
Notch signaling coordinates the patterning of striatal compartments
###end article-title 93
###begin article-title 94
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Quantitative analysis of neuronal diversity in the mouse olfactory bulb
###end article-title 94
###begin article-title 95
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
###xml 122 125 <span type="species:ncbi:10116">rat</span>
Chemical properties of type 1 and type 2 periglomerular cells in the mouse olfactory bulb are different from those in the rat olfactory bulb
###end article-title 95
###begin article-title 96
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Generation of distinct types of periglomerular olfactory bulb interneurons during development and in adult mice: implication for intrinsic properties of the subventricular zone progenitor population
###end article-title 96
###begin article-title 97
The distinct temporal origins of olfactory bulb interneuron subtypes
###end article-title 97
###begin article-title 98
Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons
###end article-title 98
###begin article-title 99
Sp8 is crucial for limb outgrowth and neuropore closure
###end article-title 99
###begin article-title 100
Production of targeted embryonic stem cell clones
###end article-title 100
###begin article-title 101
###xml 24 28 <span type="species:ncbi:10090">mice</span>
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP
###end article-title 101
###begin article-title 102
Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation
###end article-title 102

